Alaunos Therapeutics (TCRT) is scheduled to report Q3 earnings on November 13, 2026.
Alaunos Therapeutics has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Alaunos Therapeutics has averaged an EPS surprise of 0.14% and a revenue surprise of 0%.
Earnings Date
Aug 14
EPS
$-0.410
Quarterly Revenue
$0
Annual Revenue
$3K
as of Jun 30
Analyze the earnings history of Alaunos Therapeutics using advanced sorting and filters.
The chart below shows Alaunos Therapeutics's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Alaunos Therapeutics's reported revenue compared to analyst estimates over recent quarters.
Alaunos Therapeutics (TCRT) is scheduled to report earnings on November 13, 2026. The last reported earnings were for reported on August 14, 2026 for Q2.
The Actual EPS was $-0.41, which missed the estimate of $0.
The Actual Revenue was $0, which hit the estimate of $0.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Apr 1, 2024 | $-5.50 | $-4.50 | -22.2 % |
| Q3 | Nov 14, 2023 | $-6.00 | $-4.50 | -33.3 % |
| Q2 | Aug 14, 2023 | $-6.00 | $-6.00 | 0.00 % |
| Q1 | May 10, 2023 | $-6.00 | $-6.00 | 0.00 % |